Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Diabetic Cardiomyopathies

fluorodeoxyglucose f18 has been researched along with Diabetic Cardiomyopathies in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, L; Qiu, C; Shao, X; Wang, X; Wang, Y; Xu, M	1
Chen, WJ; de Roos, A; Diamant, M; Greulich, S; Lamb, HJ; Lammertsma, AA; Lubberink, M; Ouwens, DM; Rijzewijk, LJ; Romijn, JA; Ruige, JB; Smit, JW; van der Meer, RW	1
Ayer, A; Cariou, B; Charpentier, F; Dollet, L; Jagu, B; Joubert, M; Le May, C; Magré, J; Manrique, A; Marechal, X; Montaigne, D; Prieur, X; Staels, B; Tesse, A; Toumaniantz, G	1
Bergmann, SR; Giedd, KN	1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Diabetic Cardiomyopathies

Article	Year
Fatty acid imaging of the heart. Current cardiology reports, 2011, Volume: 13, Issue:2 Topics: Diabetic Cardiomyopathies; Fatty Acids; Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardial Ischemia; Myocardium; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2011

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Diabetic Cardiomyopathies

Article	Year
Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes. Cardiovascular diabetology, 2013, Oct-17, Volume: 12 Topics: Activins; Adipose Tissue; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Heart; Heart Ventricles; Humans; Hypoglycemic Agents; Inhibin-beta Subunits; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Myocardium; Myocytes, Cardiac; Organ Size; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome; Ventricular Remodeling	2013

Article

Year

Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.

Cardiovascular diabetology, 2013, Oct-17, Volume: 12

Topics: Activins; Adipose Tissue; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Heart; Heart Ventricles; Humans; Hypoglycemic Agents; Inhibin-beta Subunits; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Myocardium; Myocytes, Cardiac; Organ Size; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome; Ventricular Remodeling

2013

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Diabetic Cardiomyopathies

Article	Year
The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based BMC cardiovascular disorders, 2018, 10-29, Volume: 18, Issue:1 Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetic Cardiomyopathies; Fasting; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Middle Aged; Myocardium; Non-alcoholic Fatty Liver Disease; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sex Factors; Whole Body Imaging	2018
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model. Diabetes, 2017, Volume: 66, Issue:4 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Glucosides; GTP-Binding Protein gamma Subunits; Heart; Heterotrimeric GTP-Binding Proteins; Hyperglycemia; Hypoglycemic Agents; Lipodystrophy; Magnetic Resonance Imaging; Mice; Mice, Knockout; Myocardium; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Ventricular Dysfunction, Left; Ventricular Function	2017

Article

Year

The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based

BMC cardiovascular disorders, 2018, 10-29, Volume: 18, Issue:1

Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetic Cardiomyopathies; Fasting; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Middle Aged; Myocardium; Non-alcoholic Fatty Liver Disease; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sex Factors; Whole Body Imaging

2018

The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.

Diabetes, 2017, Volume: 66, Issue:4

Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Glucosides; GTP-Binding Protein gamma Subunits; Heart; Heterotrimeric GTP-Binding Proteins; Hyperglycemia; Hypoglycemic Agents; Lipodystrophy; Magnetic Resonance Imaging; Mice; Mice, Knockout; Myocardium; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Ventricular Dysfunction, Left; Ventricular Function

2017